Although early studies focused on the role of purinergic receptors in neurotransmission, as early as 1980 it was suggested that specific plasma membrane receptors for extracellular ATP were also expressed by inflammatory and cancer cells [7,8]. This evidence concerns the gene P2RY2 and cancer.